OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30080655

Jiangsu Sidike New Materials Science & Technology Co Ltd

Commodity ChemicalsVerified

Jiangsu Sidike operates with a capital structure that includes a debt-to-equity ratio of 1.64, indicating a relatively high reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 1.03, suggesting limited short-term liquidity cushion. Free cash flow of 315.7 million CNY supports operational flexibility, but the negative net cash position after subtracting total debt raises concerns about long-term liquidity. Profitability metrics show a return on equity (ROE) of 2.62% and a return on assets (ROA) of 0.79%, both below the typical thresholds for healthy performance in the commodity chemicals industry. Gross profit of 605.9 million CNY represents a 20.1% margin, which is in line with industry norms, but operating income of 38.3 million CNY and net income of 60.4 million CNY indicate thin operating margins and limited profitability. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and sector-specific risks. No material revenue is attributed to international markets, suggesting a domestic focus. Growth trajectory is constrained by the company's capital structure and profitability. Capital expenditures of -84.5 million CNY suggest a reduction in investment, which may limit future capacity expansion or innovation. With no disclosed revenue growth rates or forward-looking guidance, the company's ability to scale operations remains uncertain. Risk factors include medium liquidity risk and low dilution risk. The company's debt load and limited free cash flow could pressure liquidity in the event of rising interest rates or declining sales. No significant dilution events are currently expected, as shares outstanding remain unchanged between basic and diluted measures. Recent events include the latest financial filing, which discloses the company's current financial position and operational performance. No material events, such as regulatory actions or major business developments, have been reported in the latest available data.

30-day price · 300806+37.13 (+81.0%)
Low$44.80High$92.58Close$82.99As of21 May, 00:00 UTC
Profile
CompanyJiangsu Sidike New Materials Science & Technology Co Ltd
Ticker300806.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Jiangsu Sidike New Materials Science & Technology Co Ltd is a Chinese company engaged in the production and sale of commodity chemicals, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Jiangsu Sidike operates with a capital structure that includes a debt-to-equity ratio of 1.64, indicating a relatively high reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 1.03, suggesting limited short-term liquidity cushion. Free cash flow of 315.7 million CNY supports operational flexibility, but the negative net cash position after subtracting total debt raises concerns about long-term liquidity. Profitability metrics show a return on equity (ROE) of 2.62% and a return on assets (ROA) of 0.79%, both below the typical thresholds for healthy performance in the commodity chemicals industry. Gross profit of 605.9 million CNY represents a 20.1% margin, which is in line with industry norms, but operating income of 38.3 million CNY and net income of 60.4 million CNY indicate thin operating margins and limited profitability. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and sector-specific risks. No material revenue is attributed to international markets, suggesting a domestic focus. Growth trajectory is constrained by the company's capital structure and profitability. Capital expenditures of -84.5 million CNY suggest a reduction in investment, which may limit future capacity expansion or innovation. With no disclosed revenue growth rates or forward-looking guidance, the company's ability to scale operations remains uncertain. Risk factors include medium liquidity risk and low dilution risk. The company's debt load and limited free cash flow could pressure liquidity in the event of rising interest rates or declining sales. No significant dilution events are currently expected, as shares outstanding remain unchanged between basic and diluted measures. Recent events include the latest financial filing, which discloses the company's current financial position and operational performance. No material events, such as regulatory actions or major business developments, have been reported in the latest available data.
Key takeaways
  • Jiangsu Sidike has a high debt-to-equity ratio of 1.64, indicating a significant reliance on debt financing.
  • The company's ROE of 2.62% and ROA of 0.79% suggest weak profitability relative to industry standards.
  • Free cash flow of 315.7 million CNY provides some liquidity, but the negative net cash position after debt raises concerns.
  • Revenue is concentrated in a single business segment with no disclosed geographic diversification.
  • Capital expenditures are negative, signaling reduced investment in growth or innovation.
  • No significant dilution risk is currently present, but liquidity risk remains medium.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$3.02B
Gross profit$605.9M
Operating income$38.3M
Net income$60.4M
R&D
SG&A
D&A
SBC
Operating cash flow$269.0M
CapEx-$84.5M
Free cash flow$315.7M
Total assets$7.63B
Total liabilities$5.33B
Total equity$2.30B
Cash & equivalents
Long-term debt$3.79B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.30B
Net cash-$3.79B
Current ratio1.0
Debt/Equity1.6
ROA0.8%
ROE2.6%
Cash conversion4.5%
CapEx/Revenue-2.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300806Activity
Op margin1.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin20.1%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity164.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 05:00 UTCJob: 3c61b684